Infectious diseases are illnesses caused by pathogenic microorganisms like bacteria, viruses, fungi, or parasites. These diseases can spread directly or indirectly from person to person, through contaminated food or water, insect bites, or airborne transmission. Common examples include influenza, tuberculosis, COVID-19, malaria, and HIV/AIDS.
On the other hand, non-infectious diseases are not caused by infectious agents and are typically not contagious. These conditions often arise due to genetic factors, lifestyle choices, environmental exposures, or a combination of these factors. Non-infectious diseases encompass a broad range of health issues such as cardiovascular diseases (like heart disease and stroke), cancer, diabetes, autoimmune disorders, allergies, mental health disorders, and chronic respiratory conditions like asthma.
While infectious diseases are characterized by the presence and spread of pathogens, non-infectious diseases primarily arise from internal dysfunctions, external factors, or a combination of both. Both types of diseases have significant impacts on individual health, public health, and healthcare systems, albeit through different mechanisms of origin and transmission.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India